1 / 16

Treatment Effectiveness: Finding Value in Clinical Data. Part 1.

This article discusses the value of supplementing treatment efficacy research with studies of treatment effectiveness. It presents preliminary results from a clinical study evaluating the effectiveness of a treatment program for adults who stutter.

francesg
Download Presentation

Treatment Effectiveness: Finding Value in Clinical Data. Part 1.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Treatment Effectiveness:Finding Value in Clinical Data. Part 1. J. Scott Yaruss, Ph.D., CCC-SLPUniversity of Pittsburgh University of Georgia Conference on Treatment EfficacyAthens, GeorgiaMarch 20-22, 1997

  2. Purpose • To discuss the value of supplementing treatment efficacy research with studies of treatment effectiveness • To present preliminary results from a retrospective clinical study evaluating the effectiveness of a treatment program for adults who stutter

  3. But…what is the nature ofthe client’s complaint? An effective treatment is onethat successfully addressesthe client’s complaint

  4. WHO (1980) Classification • Impairment: …loss or abnormality of psychological, physiological, or anatomical structure or function… • Disability: …any restriction or lack (result-ing from impairment) of ability to perform an activity in the [normal] manner… • Handicap: …a disadvantage…resulting from an impairment or disability that limits or prevents fulfillment of a [normal] role

  5. WHO and Stuttering • Impairment: (one entry) • Impairment of speech fluency (§37.0): stuttering events

  6. Disability: (dozens of possible entries) • Disability in talking (§21.0): …restriction of ability to produce verbal messages and convey meaning... • Situational coping disability (§14.2): ...disturbance of ability to perform activities in specific situations...

  7. Handicap: (several possible entries) • Social integration handicap (§4.1):…disadvantages that inhibit but not prevent participation in social activities • Occupation handicap(§4.3):…restriction of career choice because of impairment or disability

  8. The complaintas Impairment • Some treatments apparently view the client’s complaint as the stuttering event, or the impairment • Impairment:disruptions in speech, including repetitions, prolongations, blocks, reduced speaking rate, etc. • Clinicians using this approach have done a good job of demonstrating the efficacy of their treatments

  9. The complaint as Impairment,Disability, and Handicap • Some treatments view the complaint as the stuttering disorder, encompassing all three aspects (I, D, and H) • Impairment: production of disfluencies, etc. • Disability: difficulty interacting with peers, using the phone, entering speaking situations, etc. • Handicap: shame, fear, anxiety that limits participation in social activities, difficulty getting the job they want, etc.

  10. Clinicians using these types of “whole-disorder” approaches have not done a sufficient job of demonstrating treatment efficacy.

  11. Why do people use (and recommend) these unproven treatment approaches? • Because of a perceived differences in: • the nature of the client’s complaint • the responsibility of the clinician in addressing that complaint • the scope of treatment • However, there are problems...

  12. Some Problems • With the whole-disorder approach, it can be difficult (but not impossible) to assess treatment efficacy • “Success” is based on the needs of the client • Thus, success is variable and individualized, both between and within clients (over time) • The definition of success also varies depending upon whether you’re talking about the impairment, the disability, or the handicap

  13. Consequences • Because of the individualized nature of treatment, it can be difficult to apply traditional efficacy research methods • Most single-subject designs require that the same treatment be applied across a relatively homogenous set of subjects • Group designs are not as well suited to assessing efficacy, but they also require homogeneity across subjects and treatments

  14. Some Major Problems • Many whole-disorder treatments are not well-grounded in theory, so it is difficult to define a framework for assessing treatment efficacy • Treatment variables in these approaches are not sufficiently operationalizedto permit rigorous study (at present)

  15. More Consequences • Before we can meaningfully assess the efficacy of whole-disorder treatments, we must: • Describe the treatment programs in detail • Operationalize the supposed outcomes of these treatments at all 3 levels (I, D, & H) • Determine whether clients report any benefits that can be associated with treatment • We are still very much at the beginning in assessing whole-disorder treatments

  16. A first step toward efficacy... • One way to begin asking whether whole-disorder treatment is effective is to study clients who already received treatment • “Documentation of Clinical Practice” • Such studies can help prepare us for future, more rigorous studies of the efficacy of whole-disorder treatments • Evaluating potential benefits of treatment • Defining treatment variables for further study

More Related